Long-term milrinone therapy is common in patients with advanced heart failure awaiting transplant, although there is evidence that long-term administration of inotropic therapy increases mortality ...
1 个月
MyChesCo on MSNWindtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failureheart function. Its dual-mechanism of action combines positive inotropic effects achieved through Na+/K+-ATPase inhibition ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果